Weekly Investment Newsletter

Led by large-cap technology stocks, the S&P 500 set new records last week despite the Fed’s concerns on economic recovery and mixed economic data.

Helped by the steadying COVID-19 case count, stocks sensitive to the ‘reopening’ of the economy rose despite mixed economic data and stalemate on stimulus.

Strong economic data and slowing COVID-19 infections helped stocks to rally broadly despite Washington’s failure on stimulus.

Strong earnings and comforting comments from the Fed helped stocks maintain their uptrend despite weak economic data and a divisive Congress.

Stocks were virtually unchanged last week after jobless claims data and faltering Sino-U.S. relations offset promising COVID-19 vaccine trial results.

Gains in stock prices from progress on COVID-19 vaccines were limited by mixed economic data and the continued rise in COVID-19 cases.

As COVID-19 cases continued to surge, investors sought safety in large-cap technology stocks and pushed the NASDAQ Composite Index to new all-time highs.

Stocks rose as better-than-expected economic data and positive news on an experimental COVID-19 vaccine calmed fears from rising number of COVID-19 cases.

Fears of economic damage from COVID-19 increased. The Fed restricted banks from returning capital to shareholders. Stocks closed near their two-week low.

Stocks reacted positively to retail sales data and the Federal Reserve’s decision to buy corporate bond. The rising COVID-19 case count limited the gains.